10x Genomics, Inc. TXG Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $490.29M+3.4% | $473.97M+9.5% | $432.71M+8.8% | $397.71M+5.5% | $377.06M+9.6% | ||
| $49.56M+0.2% | $49.44M-0.3% | $49.58M+0.1% | $49.55M-0.6% | $49.84M+1.0% | ||
| $39.03M-17.0% | $47.01M+7.4% | $43.78M-12.4% | $49.98M-4.9% | $52.55M-40.2% | ||
| $53.49M-5.1% | $56.34M-9.1% | $61.96M-10.2% | $68.97M-7.7% | $74.71M-10.1% | ||
| $669.73M-2.2% | $684.45M+3.7% | $659.83M+0.6% | $655.66M+13.1% | $579.73M-0.8% | ||
| $220.59M-2.7% | $226.71M-2.5% | $232.53M-3.0% | $239.71M-2.6% | $246.09M-2.6% | ||
| $4.51M0.0% | $4.51M0.0% | $4.51M0.0% | $4.51M0.0% | $4.51M0.0% | ||
| $59.91M-3.9% | $62.33M-3.8% | $64.76M+340% | $14.71M-3.1% | $15.19M-3.1% | ||
| $1.02B-2.5% | $1.04B+1.4% | $1.03B+4.8% | $979.97M+8.5% | $903.39M-1.7% | ||
| $17.43M+36.8% | $12.73M-29.5% | $18.07M+13.4% | $15.94M+58.3% | $10.07M-22.0% | ||
| $24.34M+1.8% | $23.9M+8.0% | $22.14M+3.2% | $21.45M+2.4% | $20.95M+1.4% | ||
| $113.6M-26.0% | $153.45M+4.2% | $147.32M+31.3% | $112.22M+4.0% | $107.9M-8.3% | ||
| $201.44M-17.8% | $245.04M+1.2% | $242.24M+17.2% | $206.69M+5.2% | $196.5M-5.8% | ||
| $2K0.0% | $2K0.0% | $2K0.0% | $2K0.0% | $2K0.0% | ||
| -$1.52B-0.9% | -$1.51B-1.1% | -$1.49B-1.9% | -$1.47B+2.3% | -$1.5B-2.3% | ||
| $814.32M+2.3% | $796.33M+1.4% | $785.12M+1.5% | $773.28M+9.4% | $706.9M-0.5% | ||
| $1.02B-2.5% | $1.04B+1.4% | $1.03B+4.8% | $979.97M+8.5% | $903.39M-1.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can 10x Genomics, Inc. cover its short-term obligations?
- Its current ratio is 5.90 — current assets exceed current liabilities.
- Where does 10x Genomics, Inc.'s balance sheet data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.